Skip to main content

Table 3 Work productivity assessment of patients at baseline

From: Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)

Work productivity assessment

No. of patients

Response, n (%) or mean ± SD

Employed at baseline

575

Yes: 262 (45.6)

Employed when CD symptoms began

313

Yes: 161 (51.4)

Stopped working due to CD

161

Yes: 59 (36.6)

Employment status affected by CD

262

   • Different job with less responsibility or pay: 14 (5.3)

  

   • Same job, reduced hours or responsibility: 50 (19.1)

  

   • No change: 198 (75.6)

Missed work in past month due to CD

261

Yes: 74 (28.4)

Number of missed work days in past month

74

5.7 ± 11.6

Decreased productivity due to CD

261

Yes: 150 (57.5)

Estimated decrease in work productivity (%)

150

72.1 ± 20.5

Have received disability benefits due to CD

262

Yes: 12 (4.6)

Duration of disability benefits (months)

12

33.2 ± 60.8

  1. CD: cervical dystonia; SD: standard deviation.